ZA976479B - Alfa-amino acids amides, preparation thereof and the therapeutical use thereof. - Google Patents

Alfa-amino acids amides, preparation thereof and the therapeutical use thereof.

Info

Publication number
ZA976479B
ZA976479B ZA9706479A ZA976479A ZA976479B ZA 976479 B ZA976479 B ZA 976479B ZA 9706479 A ZA9706479 A ZA 9706479A ZA 976479 A ZA976479 A ZA 976479A ZA 976479 B ZA976479 B ZA 976479B
Authority
ZA
South Africa
Prior art keywords
alfa
preparation
amino acids
therapeutical use
acids amides
Prior art date
Application number
ZA9706479A
Other languages
English (en)
Inventor
Paolo Chiesi
Paolo Ventura
Maurizio Delcanale
Renato De Fanti
Elisabetta Armani
Gino Villetti
Claudio Pietra
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ZA976479B publication Critical patent/ZA976479B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA9706479A 1996-07-23 1997-07-22 Alfa-amino acids amides, preparation thereof and the therapeutical use thereof. ZA976479B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001544A IT1283489B1 (it) 1996-07-23 1996-07-23 Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico

Publications (1)

Publication Number Publication Date
ZA976479B true ZA976479B (en) 1998-03-02

Family

ID=11374651

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9706479A ZA976479B (en) 1996-07-23 1997-07-22 Alfa-amino acids amides, preparation thereof and the therapeutical use thereof.

Country Status (26)

Country Link
US (1) US6114391A (de)
EP (1) EP0951465B1 (de)
JP (1) JP4542208B2 (de)
CN (1) CN1211351C (de)
AR (1) AR007963A1 (de)
AT (1) ATE237584T1 (de)
AU (1) AU729176B2 (de)
CA (1) CA2261259C (de)
CZ (1) CZ295824B6 (de)
DE (1) DE69721052T2 (de)
DK (1) DK0951465T3 (de)
ES (1) ES2195158T3 (de)
HU (1) HU225623B1 (de)
ID (1) ID17999A (de)
IL (1) IL128020A (de)
IT (1) IT1283489B1 (de)
MY (1) MY118244A (de)
NO (1) NO326826B3 (de)
NZ (1) NZ333869A (de)
PT (1) PT951465E (de)
RU (1) RU2174511C2 (de)
SI (1) SI0951465T1 (de)
TR (1) TR199900087T2 (de)
TW (1) TW557291B (de)
WO (1) WO1998003472A1 (de)
ZA (1) ZA976479B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672746A (en) 1994-08-30 1997-09-30 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
JP2002518442A (ja) 1998-06-22 2002-06-25 アメリカン・バイオジェネティック・サイエンシズ・インコーポレーテッド 偏頭痛及び情動病の治療及び予防用バルプロ酸類似物の用法
US20030035784A1 (en) * 2001-03-05 2003-02-20 Kao Corporation Hair cosmetic, aminocarboxylic acid amide and method for producing the same
DE60122541T2 (de) * 2001-12-21 2007-09-13 Chiesi Farmaceutici S.P.A. 2-Indanylaminoderivate zur Therapie von chronischen, akuten oder entzündlichen Schmerzen
FR2843590B1 (fr) 2002-08-14 2007-10-05 Prestwick Scient Capital Inc Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
PT1778623E (pt) * 2004-08-03 2008-09-29 Chiesi Farma Spa Derivados dos ácidos 1-fenilalcanocarboxílicos para o tratamento de doenças neurodegenerativas
WO2014178083A1 (en) 2013-05-03 2014-11-06 Council Of Scientific & Industrial Research An improved synthesis of anti-parkinson agent
CN105646252A (zh) * 2016-02-25 2016-06-08 吉尔生化（上海）有限公司 一种丝氨酸酰胺盐酸盐的合成方法
KR102286897B1 (ko) * 2019-06-25 2021-08-09 (주)앰틱스바이오 신규한 아미노알칸산에 바이페닐기를 도입한 유도체 화합물 및 이를 포함하는 항진균성 약학적 조성물
WO2022238507A1 (en) * 2021-05-11 2022-11-17 Awakn Ls Europe Holdings Limited Therapeutic aminoindane compounds and compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010599A1 (de) * 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE68928174T2 (de) * 1988-03-16 1997-12-18 Eisai Co Ltd Verfahren zur Herstellung von Cephemderivaten
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5198547A (en) * 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
US5332840A (en) * 1993-05-27 1994-07-26 Bristol-Myers Squibb Company Method for preparing a benzaldehyde intermediate

Also Published As

Publication number Publication date
TW557291B (en) 2003-10-11
RU2174511C2 (ru) 2001-10-10
EP0951465B1 (de) 2003-04-16
NO990300L (no) 1999-01-22
IL128020A (en) 2002-04-21
ID17999A (id) 1998-02-19
DE69721052T2 (de) 2004-02-05
NO990300D0 (no) 1999-01-22
JP2001506577A (ja) 2001-05-22
CN1225625A (zh) 1999-08-11
NO326826B1 (no) 2009-02-23
WO1998003472A1 (en) 1998-01-29
PT951465E (pt) 2003-08-29
CZ295824B6 (cs) 2005-11-16
NO326826B3 (no) 2010-06-07
US6114391A (en) 2000-09-05
CA2261259C (en) 2006-10-03
DK0951465T3 (da) 2003-08-11
CZ18299A3 (cs) 1999-06-16
IT1283489B1 (it) 1998-04-21
HU225623B1 (en) 2007-05-02
AR007963A1 (es) 1999-11-24
DE69721052D1 (de) 2003-05-22
JP4542208B2 (ja) 2010-09-08
CA2261259A1 (en) 1998-01-29
AU729176B2 (en) 2001-01-25
CN1211351C (zh) 2005-07-20
MY118244A (en) 2004-09-30
ATE237584T1 (de) 2003-05-15
NZ333869A (en) 2000-05-26
AU3695297A (en) 1998-02-10
IL128020A0 (en) 1999-11-30
ITMI961544A1 (it) 1998-01-23
TR199900087T2 (xx) 1999-03-22
HUP9902992A3 (en) 2004-04-28
SI0951465T1 (en) 2003-08-31
EP0951465A1 (de) 1999-10-27
ITMI961544A0 (de) 1996-07-23
ES2195158T3 (es) 2003-12-01

Similar Documents

Publication Publication Date Title
EP1032377A4 (de) Substituierte 2-aminoacetamide und anwendung davon
IL128800A0 (en) 4-Heteroylpyrazol derivatives and the use thereof as herbicides
SI1019358T2 (sl) 3,3-diarilpropilamini, njihova uporaba in priprava
EP0710667A3 (de) Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
ZA964710B (en) Novel compounds, the preparation and use thereof.
HUP0004463A3 (en) Fluoropyrazole-biphenylamide fungicides, preparation and use thereof
ZA976222B (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use.
HU9501086D0 (en) Organoaluminoxy product, preparation and use
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
EP0669332A3 (de) Substituierte Naphthyridine und deren herbizide Verwendung.
IL125631A0 (en) Halogenating agents and processes for the preparation thereof
HUP0001603A3 (en) Cycloalkylalkanecarboxamides and the production and use thereof
ZA976479B (en) Alfa-amino acids amides, preparation thereof and the therapeutical use thereof.
IL129927A0 (en) 1,4-Diazabicyclo (2.2.2) oct-2-ylmethyl derivatives their preparation and therapeutic application
EP0890599A4 (de) Polyorganosiloxane und verfahren zu deren herstellung
EP0738144A4 (de) Phenyl methyl hexan amide und deren verwendung
IL114305A0 (en) 2,4,6-triiodo-5-substituted-amino-isophthalate esters and their use
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
HUP9600730A1 (en) 1,4-tetrazolinone-derivatives and use thereof as herbicides
HUP0000498A3 (en) Novel calpaines, production and use thereof
ZA9711047B (en) Formulation and use.
ZA955128B (en) Novel amido-quinoxalinediones the preparation and use thereof
EP0586154A3 (de) Die Melaninbildung hemmendes Protein, seine Herstellung und Anwendungen.
EP0592941A3 (de) Polyamidzusammensetzung und Verwendung.